Anesthesia for Cardiac Surgery

  • Bradley J. Harlan
  • Albert Starr
  • Fredic M. Harwin
  • Alain Carpentier


Anesthesia for cardiac surgery is often more demanding than anesthesia for other types of surgery. Almost all patients have hemodynamic abnormalities that must be managed properly during induction and maintenance of anesthesia in order to avoid myocardial injury or injury to other organs.


Anesthetic Agent Myocardial Oxygen Consumption Myocardial Oxygen Demand Coronary Artery Surgery Inhalational Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anand KJS, Hickey PR: Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 326:1,1992.PubMedCrossRefGoogle Scholar
  2. 2.
    Basseil GM, Lin YT, Oka Y, Becker RM, Frater RWM: Circulatory response to tracheal intubation in patients with coronary artery disease and valvular disease. Bull NY Acad Med 54:842,1978.Google Scholar
  3. 3.
    Becker LC: Is isoflurane dangerous for the patient with coronary artery disease? Anesthesiology 66:259,1987.PubMedCrossRefGoogle Scholar
  4. 4.
    deLange S, Boscoe MJ, Stanley TH, Pace N: Comparison of Sufentanil-Oxygen and Fentanyl-Oxygen for coronary artery surgery. Anesthesiology 56:112,1982.CrossRefGoogle Scholar
  5. 5.
    Hickey PR, Hansen DD, Wessel DL, Lang P, Jonas RA: Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg 64:483,1985.PubMedGoogle Scholar
  6. 6.
    Howie MB, McSweeney TD, Lingam RP, Maschke SP: A comparison of fentanyloxygen and sufentanil-oxygen for cardiac anesthesia. Anesth Analg 64:877,1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Isom OW, Spencer FC, Feigenbaum H, Cunningham J, Roe C: Prebypass myocardial damage in patients undergoing coronary revascularization: an unrecognized vulnerable period (abstr). Circulation 51(Suppl II):II–119,1975.Google Scholar
  8. 8.
    Kaplan JA (ed): Cardiac Anesthesia. New York, San Francisco, London, Grune & Stratton, 1979.Google Scholar
  9. 9.
    Kaplan JA, King SB: The precordial electrocardiographic lead (V5) in patients who have coronary artery disease. Anesthesiology 45:570,1976.PubMedCrossRefGoogle Scholar
  10. 10.
    Kitamura K, Jorgensen CR, Gobel F, Taylor HL, Wang Y: Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32:516,1972.PubMedGoogle Scholar
  11. 11.
    Leung JM, Goehner P, O’Kelly BF, Hollenberg M, Pineda N, Cason BA, Mangano DT: Isoflurane anesthesia and myocardial ischemia: comparative risk versus sufentanil anesthesia in patients undergoing coronary artery bypass graft surgery. Anesthesiology 74:838,1991.PubMedCrossRefGoogle Scholar
  12. 12.
    Lowenstein E, Hallowel P, Levin FH, Daggett WM, Austen WG, Laver MB: Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med 281:1389,1969.PubMedCrossRefGoogle Scholar
  13. 13.
    Mathews HML, Furness G, Carson IW, Orr IA, Lyons SM, Clarke RSJ: Comparison of sufentanil-oxygen and fentanyl-oxygen anesthesia for coronary artery bypass grafting. Br J Anaesth 60:530,1988.PubMedCrossRefGoogle Scholar
  14. 14.
    Moore CH, Lombardo TR, Allums JA, Gordon FT: Left main coronary artery stenosis: hemodynamic monitoring to reduce mortality. Ann Thorac Surg 26: 445,1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Moore RA, Yang SS, McNicholas KW, Gallagher JD, Clark DL: Hemodynamic and anesthetic effects of sufentanil as the sole anesthetic for pediatric cardiovascular surgery. Anesthesiology 62:725,1985.PubMedCrossRefGoogle Scholar
  16. 16.
    Morris RB, Cahalan MK, Miller RD, Wilkinson PL, Quasha AL, Robinson SL: The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology 58:438,1983.PubMedCrossRefGoogle Scholar
  17. 17.
    Nelson RR, Gobel RL, Jorgennsen CR, Wang K, Wang Y, Taylor HL: Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50:1179,1974.PubMedGoogle Scholar
  18. 18.
    O’Young J, Mastrocostopoulos G, Hilgenberg A, Palacios I, Kyritsis A, Lappas DG: Myocardial circulatory and metabolic effects of isoflurane and sufentanil during coronary artery surgery. Anesthesiology 66:653,1987.PubMedCrossRefGoogle Scholar
  19. 19.
    Reiz S, Balfors E, Sorensen MB, Ariola S, Friedman A, Truedsson H: Isoflurane- a powerful coronary vasodilator in patients with coronary artery disease. Anesthesiology 59:91,1983.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosow CE: Sufentanil citrate: a new opioid for use in anesthesia. Pharmacotherapy 4:11,1984.PubMedGoogle Scholar
  21. 21.
    Slogoff S, Keats AS: Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 70:179,1989.PubMedCrossRefGoogle Scholar
  22. 22.
    Sonnenblick EK, Ross J Jr, Braunwald E: Oxygen consumption of the heart: newer concepts of its multifactorial determination. Am J Cardiol 22:328,1968.PubMedCrossRefGoogle Scholar
  23. 23.
    Stanley TH, Webster LR: Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg 57:411,1978.PubMedGoogle Scholar
  24. 24.
    Thomson IR, Hudson RJ, Rosenbloom M, Meatherall RC: A randomized doubleblind comparison of fentanyl and sufentanil anaesthesia for coronary artery surgery. Can J Anaesth 34:227,1987.PubMedCrossRefGoogle Scholar
  25. 25.
    Tomicheck RC, Rosow CE, Philbin DM, Moss J, Teplick RS, Schneider RC: Diaze-pam-fentanyl interaction—hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg 62:881,1983.PubMedCrossRefGoogle Scholar
  26. 26.
    Turman KJ, McCarthy RJ, Speiss BD, DaValle M, Dabir R, Ivankovich AD: Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 70:189,1989.CrossRefGoogle Scholar
  27. 27.
    Tweed WA, Minuck M, Mymin D: Circulatory responses to ketamine anesthesia. Anesthesiology 37:613,1972.PubMedCrossRefGoogle Scholar
  28. 28.
    Wilkinson PL, Moyers JR, Ports T, Chatterjee K, Ullyot DJ, Hamilton WK: Rate pressure product and myocardial oxygen consumption during surgery for coronary artery bypass. Circulation 58(Suppl II):II–84,1978.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1995

Authors and Affiliations

  • Bradley J. Harlan
    • 1
    • 2
    • 3
  • Albert Starr
    • 3
    • 4
    • 5
  • Fredic M. Harwin
    • 6
  • Alain Carpentier
    • 7
  1. 1.Section of Thoracic and Cardiovascular SurgerySutter Memorial HospitalSacramentoUSA
  2. 2.Davis Medical SchoolUniversity of CaliforniaSacramentoUSA
  3. 3.Oregon Health Sciences UniversityPortlandUSA
  4. 4.Heart Institute at St. Vincent HospitalPortlandUSA
  5. 5.Starr-Wood Cardiac Group, P.C.PortlandUSA
  6. 6.Harwin StudiosPortlandUSA
  7. 7.Hôpital BroussaisUniversity of ParisParisFrance

Personalised recommendations